Indeed, we found that pharmacological inhibition of IGF2/IGF1R signaling with linsitinib decreased AKT phosphorylation and attenuated bladder cancer cells’ SOX2-mediated colony-forming ability. Here, IGF1R is linked to urinary bladder carcinoma.